References
- Chang T.M.S. Semipermeable microcapsules. Science 1964; 146(3643)524–525
- Chang T.M.S. Stabilization of enzyme by microencapsulation with a concentrated protein solution or by crosslinking with glutaraldehyde. Biochem Biophys. Res Com 1971; 44: 1531–1533
- Chang, T.M.S. 1997. Monograph on Blood Substitutes: Principles, Methods, Products and Clinical Trials. Karger (ed.), Basel, Switzerland.
- Chang T.M.S. Monograph on ARTIFICIAL CELLS: Biotechnology, Nanotechnology, Blood Substitutes, Regenerative Medicine, Bioencapsulation, Cell/Stem Cell Therapy. World Science Publisher, Singapore 2007
- Chang T.M.S. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory. Biochimica et Biophysica Acta: Proteins & Proteomics 2008; 1784: 1435–1443
- Gould S. A., et al. The life-sustaining capacity of human polymerized Hb when red cells might be unavailable. J. Am. Coll. Surg. 2002; 195: 445–452
- Millipore. 2003. Protein Concentration and Diafiltration by Tangential Flow Filtration. From http://www.millipore.com/publications.nsf/docs/tb032.
- Millipore . 2009. Pellicon XL 50 Devices: Specifications. http://www.millipore.com/catalogue.nsf/docs/C1974.
- Moore E.E., et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: The USA multicenter trial. J Am Coll Surg. 2009; 208: 1–13
- Pearce L.B., Gawryl M.S., . HBOC- 201 (Hb Glutamer-250 (Bovine), Hemopure): clinical studies. Blood Substitutes, R. Winslow, et al. Academic Press, San Diego 2006; 437–450
- Yu B.L., Liu Z.C., Chang T.M.S. PolyHb with different percentage of tetrameric Hb and effects on vasoactivity and electrocardiogram. Artificial Cells. Blood Substitutes & Biotechnology 2006; 34: 159–175